Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
N/A
178 Added 169.52%
283 $1,000
Q1 2024

Nov 05, 2024

SELL
N/A
-178 Reduced 62.9%
105 $0
Q1 2024

May 15, 2024

SELL
N/A
-66 Reduced 38.6%
105 $0
Q4 2023

Feb 14, 2024

BUY
N/A
160 Added 1454.55%
171 $0
Q3 2023

Nov 14, 2023

BUY
N/A
11 New
11 $0
Q3 2022

Nov 14, 2022

BUY
$3.93 - $6.08 $2,043 - $3,161
520 Added 6500.0%
528 $2,000
Q2 2022

Aug 15, 2022

BUY
$4.01 - $5.85 $32 - $46
8 New
8 $0

Others Institutions Holding GRVI

About GROVE, INC.


  • Ticker GRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,819,800
  • Market Cap $83.3M
More about GRVI
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.